+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

LAMEA Cardiac Catheters & Guidewires Market Size, Share & Industry Trends Analysis Report by Product (Cardiac Catheters and Cardiac Guidewires), End-user (Hospitals, Clinics and Ambulatory Surgical Centers), Country and Growth Forecast, 2022-2028

  • PDF Icon

    Report

  • 105 Pages
  • October 2022
  • Region: Africa, Middle East
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5694668
The Latin America, Middle East and Africa Cardiac Catheters & Guidewires Market should witness market growth of 12.1% CAGR during the forecast period (2022-2028).

A tiny angioplasty balloon catheter is advanced over a guidewire that has been placed past the stenosis through the lumen. After that, the balloon catheter is inflated and placed into the artery across the stenotic region. The stenotic region enlarges due to this inflation, allowing blood flow to resume. The balloon is then removed, deflated, and replaced with a stent that stays in place.

A frequent technique that is typically well tolerated is cardiac catheterization. The advantages of the procedure and any related pharmacological therapy should be known to pharmacists. Community pharmacists are well-positioned to respond to patients' inquiries about the cardiac catheterization procedure as well as the necessity of adhering to DAPT after being released from the hospital.

In hospital settings, pharmacists can help patients make drug decisions and create a formulary of anti-platelets & anticoagulants for the procedure. In order to prevent future cardiovascular incidents, these pharmacists can also make sure that patients are released on the proper antiplatelet treatment.

The ageing of the local population is one factor contributing to the rise in illnesses. According to Statistics South Africa's most recent mid-year population projections, the country of South Africa has an estimated population of 56.5 million people (Stats SA). The nation's healthcare sector is also thriving. In particular for primary care, the government is the biggest purchaser of medical supplies and equipment. Therefore, it is that the incidence of cardiac catheterization would increase in the region as a result of the rising prevalence of such illness and the fast-growing healthcare infrastructure of the regional countries.

The Brazil market dominated the LAMEA Cardiac Catheters & Guidewires Market by Country in 2021; thereby, achieving a market value of $356.2 million by 2028. The Argentina market is exhibiting a CAGR of 12.7% during (2022-2028). Additionally, The UAE market would obtain a CAGR of 11.8% during (2022-2028).

Based on Product, the market is segmented into Cardiac Catheters and Cardiac Guidewires. Based on Cardiac Catheters Type, the market is segmented into Electrophysiology Catheters, PTCA Balloons Catheters, IVUS Catheters, PTA Balloons Catheters, Guide Extension Catheters and Others. Based on End-user, the market is segmented into Hospitals, Clinics and Ambulatory Surgical Centers. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Getinge AB, Cardinal Health, Inc., Biotronik SE & Co. KG, Medtronic PLC, Nipro Corporation, Merit Medical Systems, Inc., Teleflex, Inc. and B. Braun Melsungen AG

Scope of the Study

By Product

  • Cardiac Catheters
    • Electrophysiology Catheters
    • PTCA Balloons Catheters
    • IVUS Catheters
    • PTA Balloons Catheters
    • Guide Extension Catheters
    • Others
  • Cardiac Guidewires

By End-user

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Getinge AB
  • Cardinal Health, Inc.
  • Biotronik SE & Co. KG
  • Medtronic PLC
  • Nipro Corporation
  • Merit Medical Systems, Inc.
  • Teleflex, Inc.
  • Braun Melsungen AG

Unique Offerings

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Cardiac Catheters & Guidewires Market, by Product
1.4.2 LAMEA Cardiac Catheters & Guidewires Market, by End-user
1.4.3 LAMEA Cardiac Catheters & Guidewires Market, by Country
1.5 Research Methodology
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 The Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
Chapter 4. LAMEA Cardiac Catheters & Guidewires Market by Product
4.1 LAMEA Cardiac Catheters Market by Country
4.2 LAMEA Cardiac Catheters & Guidewires Market by Cardiac Catheters Type
4.2.1 LAMEA Electrophysiology Catheters Market by Country
4.2.2 LAMEA PTCA Balloons Catheters Market by Country
4.2.3 LAMEA IVUS Catheters Market by Country
4.2.4 LAMEA PTA Balloons Catheters Market by Country
4.2.5 LAMEA Guide Extension Catheters Market by Country
4.2.6 LAMEA Others Market by Country
4.3 LAMEA Cardiac Guidewires Market by Country
Chapter 5. LAMEA Cardiac Catheters & Guidewires Market by End-user
5.1 LAMEA Hospitals Market by Country
5.2 LAMEA Clinics Market by Country
5.3 LAMEA Ambulatory Surgical Centers Market by Country
Chapter 6. LAMEA Cardiac Catheters & Guidewires Market by Country
6.1 Brazil Cardiac Catheters & Guidewires Market
6.1.1 Brazil Cardiac Catheters & Guidewires Market by Product
6.1.1.1 Brazil Cardiac Catheters & Guidewires Market by Cardiac Catheters Type
6.1.2 Brazil Cardiac Catheters & Guidewires Market by End-user
6.2 Argentina Cardiac Catheters & Guidewires Market
6.2.1 Argentina Cardiac Catheters & Guidewires Market by Product
6.2.1.1 Argentina Cardiac Catheters & Guidewires Market by Cardiac Catheters Type
6.2.2 Argentina Cardiac Catheters & Guidewires Market by End-user
6.3 UAE Cardiac Catheters & Guidewires Market
6.3.1 UAE Cardiac Catheters & Guidewires Market by Product
6.3.1.1 UAE Cardiac Catheters & Guidewires Market by Cardiac Catheters Type
6.3.2 UAE Cardiac Catheters & Guidewires Market by End-user
6.4 Saudi Arabia Cardiac Catheters & Guidewires Market
6.4.1 Saudi Arabia Cardiac Catheters & Guidewires Market by Product
6.4.1.1 Saudi Arabia Cardiac Catheters & Guidewires Market by Cardiac Catheters Type
6.4.2 Saudi Arabia Cardiac Catheters & Guidewires Market by End-user
6.5 South Africa Cardiac Catheters & Guidewires Market
6.5.1 South Africa Cardiac Catheters & Guidewires Market by Product
6.5.1.1 South Africa Cardiac Catheters & Guidewires Market by Cardiac Catheters Type
6.5.2 South Africa Cardiac Catheters & Guidewires Market by End-user
6.6 Nigeria Cardiac Catheters & Guidewires Market
6.6.1 Nigeria Cardiac Catheters & Guidewires Market by Product
6.6.1.1 Nigeria Cardiac Catheters & Guidewires Market by Cardiac Catheters Type
6.6.2 Nigeria Cardiac Catheters & Guidewires Market by End-user
6.7 Rest of LAMEA Cardiac Catheters & Guidewires Market
6.7.1 Rest of LAMEA Cardiac Catheters & Guidewires Market by Product
6.7.1.1 Rest of LAMEA Cardiac Catheters & Guidewires Market by Cardiac Catheters Type
6.7.2 Rest of LAMEA Cardiac Catheters & Guidewires Market by End-user
Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent Strategies and Developments
7.1.5.1 Acquisitions and Mergers
7.1.5.2 Approvals and Trials
7.1.6 SWOT Analysis
7.2 Boston Scientific Corporation
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent Strategies and Developments
7.2.5.1 Acquisition and Mergers
7.2.6 SWOT Analysis
7.3 Medtronic PLC
7.3.1 Company overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent Strategies and Developments
7.3.5.1 Product Launches and Product Expansions
7.3.5.2 Acquisition and Mergers
7.3.5.3 Approvals and Trials
7.3.6 SWOT Analysis
7.4 Cardinal Health, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Recent Strategies and Developments
7.4.4.1 Product Launches and Product Expansions
7.5 Merit Medical Systems, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 Recent Strategies and Developments
7.5.5.1 Product Launches and Product Expansions
7.5.5.2 Acquisition and Mergers
7.6 Teleflex, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 Recent Strategies and Developments
7.6.5.1 Approvals and Trials
7.6.5.2 Product Launches and Product Expansions
7.7 Getinge AB
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.8 Nipro Corporation
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expenses
7.9 B. Braun Melsungen AG
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expenses
7.9.5 Recent Strategies and Developments
7.9.5.1 Partnerships, Collaborations, and Agreements
7.10. Biotronik SE & Co. KG
7.10.1 Company Overview
7.10.2 Recent Strategies and Developments
7.10.2.1 Product Launches and Product Expansions

Companies Mentioned

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Getinge AB
  • Cardinal Health, Inc.
  • Biotronik SE & Co. KG
  • Medtronic PLC
  • Nipro Corporation
  • Merit Medical Systems, Inc.
  • Teleflex, Inc.
  • B. Braun Melsungen AG

Methodology

Loading
LOADING...